People with type 2 diabetes who take insulin can switch from daily basal insulin injections to weekly injections of Onswik ...

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, ...

Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

A modified insulin that can prevent sudden drops in blood sugar has been demonstrated in laboratory experiments and animal models, reports a paper in Nature. This could provide a more flexible way to ...

The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...

The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering an alternative to ...

Share on Pinterest Recent clinical trials indicate that once-weekly insulin injections are on the horizon as a treatment for diabetes. Catherine Falls Commercial/Getty Images A year-long phase 3 ...

From insulin inhalers to epinephrine nasal sprays, new delivery systems are making some lifesaving drugs easier to take.

Approval marks the second once-weekly basal insulin for this population ...

The FDA has granted 510(k) clearance for an insulin titration algorithm that uses continuous glucose monitoring and insulin ...

The FDA approved Onswik, a once-weekly basal insulin for adults with type 2 diabetes. Here's how it works, who it's for and ...